Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2015Human Molecular GeneticsOpen Access

Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAnastasia G. HenryUniversity of California, San FranciscoSASoheil AghamohammadzadehLysosomal Therapeutics (United States)HSHarry SamarooPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Henry et al. (2015) studied this question.

synapsesocial.com/papers/6a706063f44fa9f079de00dchttps://doi.org/10.1093/hmg/ddv314
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New assay using fluorogenic substrates and immunofluorescence staining to measure cysteine cathepsin activity in live cell subpopulations2007 · 44 citations
  2. 2Regulation Mechanisms and Signaling Pathways of Autophagy2009 · 3,624 citations
  3. 3Inhibition of LRRK2 kinase activity stimulates macroautophagy2013 · 155 citations
  4. 4Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies2013 · 64 citations
  5. 5LRRK2 Inhibition Attenuates Microglial Inflammatory Responses2012 · 482 citations